novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Peri-procedural management of patients taking oral anticoagulants

23 Novembro 2015

Paul Daniels BMJ 2015;351:h2391

Tags:
Antitrombóticos

Andexanet Alfa for the Reversal od Factor Xa Inhibitor Activity

23 Novembro 2015
0

6th Challenges in Cardiology

16 Fevereiro 2016
0

-->